- Contact The DPO Centre
- +44 (0)203 797 1289
- hello@dpocentre.com
March 2, 2026
In fast-moving clinical trial set-ups, General Data Protection Regulation (GDPR) governance and compliance can often seem like another layer of operational complexity. However, the challenge is rarely the regulation itself but uncertainty around how to interpret and apply it in practice. When expectations are not fully aligned across sponsors, CROs, and trial teams, this can increase risk and delay study timelines.
October 27, 2025
On 4 September, the Court of Justice of the European Union (CJEU) delivered an important judgement in European Data Protection Board (EDPS) vs Single Resolution Board (SRB), providing fresh clarification on the status of pseudonymised data under the EU General Data Protection Regulation (GDPR).
June 9, 2025
In Part 3 of our clinical trials blog series, we explore the key GDPR considerations sponsors should address when preparing and localising Informed Consent Forms (ICFs). […]
May 12, 2025
Data Processing Agreements (DPAs) are legally required under the EU and UK General Data Protection Regulation (GDPR) whenever clinical trial sponsors use third-party vendors to process […]
April 14, 2025
In this first part of our clinical trials blog series, we explore some of the key data protection considerations that sponsors need to cover in Clinical […]
September 16, 2024
Clinical trial sponsors often face challenges when it comes to selecting the right lawful basis for clinical trial data processing. Key questions include whether the choice […]
July 24, 2023
Outlining risk reduction for CROs, sponsors & partners conducting clinical trials Clinical Trials are vital to the research and development cycle in life sciences organisations, and […]
July 19, 2023
Introduction & anonymisation techniques Effective anonymisation is an issue for many organisations, however the process remains a crucial tool in safeguarding privacy rights and ensuring […]
November 28, 2022
The European Health Data Space (EHDS) Regulation marks one of the most significant milestones in the EU’s data and digital health strategy to date. It is structured into two core areas: primary use for patients and secondary use for clinical trials and research.
September 5, 2022
Clinical trials have been at the forefront of many peoples’ minds recently due to the COVID-19 pandemic, and the vaccination trials that were completed in record […]